Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

Annals of Internal Medicine

Volumn 133, Issue 1, 2000, Pages 21-30

  Paterson, David L ^b   Swindells, Susan ^c   Mohr, Jeffrey ^c   Brester, Michelle ^c   Vergis, Emanuel N ^a   Squier, Cheryl ^a   Wagener, Marilyn M ^a   Singh, Nina ^a   Hudson, Barbara ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d Veterans Affairs Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ADULT; ARTICLE; CLINICAL TRIAL; DEATH; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONITOR; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT FAILURE; UNITED STATES; VIRUS LOAD;

EID: 0034604276     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-1-200007040-00004     Document Type: Article

References (32)

1. Hogg RS, Health KV, Yip B, Craib KJ, O'Shaugnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450-4.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60.
3. Montaner JS, Hogg R, Raboud J, Harrigan R, O'Shaughnessy M. Antiretroviral treatment in 1998. Lancet. 1998;352:1919-22.
4. Deeks S, Loftus R, Cohen P, Chin S, Grant R. Incidence and predictors of virologie failure to indinavir (IDV) and/or ritonavir (RTV) in an urban health clinic [Abstract]. In: 37th International Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Washington, DC: American Soc for Microbiology; 1997:.
5. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:1977-83.
6. Bangsberg DR, Hecht FM, Charlebois EC, Zolopa AR, Holodniy M, Sheiner L, et al. Spontaneous adherence (ADH) audits (SAA) predict viral suppression in the REACH cohort [Abstract]. In: Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, 31 January-4 February 1999. Alexandria, VA: Foundation for Retrovirology and Human Health; 1999:84.
7. Buchsbaum DG, Buchanan RG, Welsh J, Centor RM, Schnoll SH. Screening for drinking disorders in the elderly using the CAGE questionnaire. J Am Geriatr Soc. 1992;40:662-5.
8. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;6:561-71.
9. Lyketsos CG, Hutton H, Fishman M, Schwartz J, Treisman GJ. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS. 1996; 10:1033-9.
10. Zieh J, Temoshok L. Perceptions of social support in men with AIDS and ARC: relationships with distress and hardiness. Journal of Applied and Social Psychology. 1987;17:193-215.
11. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261-9.
12. Waterhouse DM, Calzone KA, Mele C, Brenner DE. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol. 1993;11:1189-97.
13. Kastrissios H, Suarez JR, Katzenstein D, Girard P, Sheiner LB, Blaschke T. Characterization patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS. 1998;12:2295-303.
14. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
15. Eldred U, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:117-25.
16. Besch CL, Morse E, Simon P, Hodges J, Franchino B. Preliminary results of a compliance study within CPCRA 007 Combination Nucleoside Study (NuCombo). For the Terry Beirn Community Programs for Clinical Research on AIDS [Abstract]. In: Program and Abstracts of the 4th National Conference on Retroviruses and Opportunistic Infections, 22-26 January 1997, Washington, D.C. Alexandria, VA: Infectious Diseases Soc of America for the Foundation for Retrovirology and Human Health; 1997:111.
17. Lopez-Suarez A, Femandez-Gutierrez del Alam C, Perez-Guzman E, Giron-Gonalez JA. Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients [Letter]. AIDS. 1998;12:685-6.
18. Rodriguez-Rosado R, Jimenez-Nacher I, Soriano V, Anton P, Gonzalez-Lahoz J. Virological failure and adherence to antiretroviral therapy in HIV-infected patients [Letter]. AIDS. 1998;12:1112-3.
19. Hecht FM. Measuring HIV treatment adherence in clinical practice. AIDS Clinical Care. 1998;10:57-9.
20. Young JL, Zonana HV, Shepler L. Medication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law. 1986; 14:105-22.
21. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 1994;16:110-7.
22. Draine J, Solomon P. Explaining attitudes toward medication compliance among a seriously mentally ill population. J Nerv Ment Dis. 1994; 182: 50-4.
23. Camey R, Freedland K, Eisen S, Rich J, Jaffe A. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88-90.
24. Pugh R. An association between hostility and poor adherence to treatment in patients suffering from depression. Br J Med Psychol. 1983;56(Pt 2):205-8.
25. Fernandez F, Ruiz P. Psychiatric aspects of HIV disease. South Med J. 1989;82:999-1004.
26. Gallant JE, Block DS. Adherence to antiretroviral regimens in HIV-infected patients: result of a survey among physicians and patients. Journal of the International Association of Physicians in AIDS Care. 1998;May:32-5.
27. Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11:1665-70.
28. Anderson RJ, Kirk LM. Methods of improving patient compliance in chronic disease states. Arch Intern Med. 1982;142:1673-5.
29. Gatley MS. To be taken as directed. J R Coll Gen Pract. 1968;16:39-44.
30. Malahey B. The effect of instructions and labeling in the number of medication errors made by patients at home. American Journal of Hospital Pharmacology. 1966;23:283-92.
31. Porter AM. Drug defaulting in general practice. BMJ. 1969;1:218-22.
32. Samet JH, Libman H, Steger KA, Dhawan RK, Chen J, Shevitz AH, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type I: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92:495-502.